
LDA Therapy uses extremely low doses of allergens combined with an enzyme, beta-glucuronidase, to desensitize the immune system. This process helps the body develop tolerance to allergens by stimulating T suppressor cells. The therapy is given through intradermal injections, usually on the forearm, and requires a commitment to long-term treatments to see lasting benefits. The therapy is effective for many types of allergic reactions and can be tailored to suit individual needs.
Yes, LDA Therapy is designed with safety in mind. The doses used are extremely low, reducing the risk of severe reactions such as anaphylaxis. Most patients experience only minor localized skin reactions at the injection site. However, for those with severe symptoms, pre-treatment with steroids may be recommended to minimize any risk. Overall, LDA is a safe option for allergy sufferers.
Results with LDA Therapy can vary depending on the severity and duration of the allergy. While some patients may experience immediate relief, it may take 2-4 years of consistent treatment to achieve the full benefits, especially for long-standing or complex allergic conditions. Regular follow-up injections every 2-4 months are needed to maintain symptom relief.
For most patients, LDA Therapy requires injections every two months. However, the frequency may be adjusted based on individual progress, with treatments potentially becoming spaced further apart as symptoms improve. For seasonal allergies, treatments may be limited to 1-3 times per year, with the first dose administered several months before the allergy season.